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Conclusion: An important influencing factor remains vicinity 
to the OAR. It is possible to achieve falloff rates of 100-80% 
within a distance of 2 mm and a 100% to 50% fall within 7 
mm. This data can help enable select patients for upfront STS 
versus fractionated SRT during initial assessment of patients.  
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Purpose or Objective: To compare and analyze the 
characteristics of static intensity-modulated radiotherapy(s-
IMRT) versus constant dose rate and constant angle speed 
intensity modulated arc therapy(c-IMAT) in the treatment of 
upper thoracic and cervical esophagus cancer. By Delta4 
verified the commissioning of c-IMAT implementation in the 
Varian Clinical 23IX accelerator. 
 
Material and Methods: Eleven esophageal neoplasms patients 
treated with step-and-shoot s-IMRT at our hospital, were 
replannedusing c-IMAT. The plans were generated with 
Oncentra ver4.1 planning system, PTV were prescribed to 60 
Gy in 30 fractions. Planning objectives for PTV corresponding 
with the IMRT plans，were at least 95% planning target 
volumereached the prescription dose and V110 no more than 
10％．The maximum dose of spinal-cord was constrained 
below 45 Gy. Pared-sample T-test were applied to dose 
volume values for PTV and OAR from DVH． 
 
Results: There were no significant differences between s-
IMRT and c-IMAT in 
PTVmin，D90，D95，D98，V90，V95，V100，V105，V110，D
max or total lung V10，V20，V25，V30 and average lung dose 
(all P>0.05)．However, the differences were significant in 
terms of D2, D50, V105, PTVaverage, HI and CI of PTV，V5 
and V15 of the total lung (all P<0.05)(see table1 and 
figure1)．And treatment times were reduced significantly 
with c-IMAT(81s vs. 238.4s, p < 0.05), while, MU increased by 
a factor of 1.2, s-IMRT is 513.5MU versus c-IMAT is 624.1 MU 
(P=0.000). For the gamma Index (±3%, ±3mm), the s-IMRT 
(94.0±0.9 %) is higher than c-IMAT(91.9±1.1%), but all can 
meet the clinical demands (≥ 90%). 
 
 
 
 
 
 
Conclusion: In Varian Clinical 23IX accelerator designed c- 
IMAT plan can achieve similar or better dosimetry with s-
IMRT, having better PTV homogeneity and conformal index, 
much less treatment time advantage, and so the c- IMAT plan 
can be implemented smoothly and quickly into a busy cancer 
center, but the total MU and the average does of lung 
increased compared with s-IMRT.Hence in the treatment of 
upper thoracic and cervical esophagus cancer patients an 
evaluation of weight loss must be performed during 
treatment for C-IMAT. 
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Purpose or Objective: 
Introduction Postoperative endometrial carcinoma patients 
with large volume of target area and the shape of the target 
area is concave, treatment with IMRT is time 
consuming.Treated with VMAT can produce similar or better 
dose distributions, also can reduce treatment time and the 
monitor units (MU)[1,2]. However, VMAT can only be 
implemented on the new generation accelerators such as the 
Varian RapidArc and Elekta Synergy, which prevents most 
existing linacs from delivering in VMAT. R Zhang et al.[3] had 
been proposed an alternative planning approach for VMAT 
using constant dose-rate and constant gantry speed arc 
therapy (CDR-CAS-IMAT) implementation on Varian 23EX for 
thoracic esophageal carcinoma, the results showing that the 
treatment times compared with the IMRT technology were 
decresed significantly can be reached to 62.9%.  
Objective The purpose of this study is to investigate using 
CDR-CAS-IMAT on Varian 23IX, by comparing with the IMRT to 
evaluate the performance of CDR-CAS-IMAT on postoperative 
endometrial carcinoma patients and then provide guidance 
for clinical treatment.  
 
Material and Methods: 30 postoperative endometrial 
carcinoma patients treated with IMRT on Varian 23IX were 
replanted using CDR-CAS-IMAT. The plans were generated on 
Oncentra v4.1 planning system, PTV was prescribed to 50.4 
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Gy in 28 fractions. Plans were evaluated based on the ability 
to meet the dose volume histogram. The homogeneity index 
(HI), conformity index (CI) of target volume, the dose of 
organs at risk, radiation delivery time and monitor units were 
also compared. Paired T-test model analysis was used to 
analyse the two sets of data.  
 
Results: The results showing that postoperative endometrial 
carcinoma can be implemented CDR-CAS-IMAT plans on 
conventional Varian 23EX Linac for smoothly and quickly at 
busy cancer center. Comparing with the IMRT techonology 
CDR-CAS-IMAT plans can meet the clinical demand(see 
Figure1), gives comparable OAR and improved CI of PTV (see. 
Table 1), can reduction treatment time ((84.6±7.8)s Vs. 
(422.7±46.7)s), MU((787.5±78.5)MU Vs.(927.4±79.1)MU) and 
high dose irradiated volume; while increase the low dose 
irradiated volume of healthy tissues and the volume of the 
bladder and bowel irradiated 40 Gy and 30Gy, respectively. 
This point needs to pay attention to implementation in 
clinical. There were no significant differences in other 
statistical index.  
 
 
 
 
 
 
Conclusion: Endometrial carcinoma patients with CDR-CAS-
IMAT on Varian Clinical 23IX can get equivalent or superior 
dose distribution compared with the IMRT technology. CDR-
CAS-IMAT have much less treatment time and MU can reduce 
the uncertainty factor and patient discomfort in treatment.  
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Purpose or Objective: Aim of this study was to determine 
the dosimetric impact of flatting filter free beam (FFFB) of 6 
and 10 MV energies on rapid-arc (RA) radiotherapy planning 
for gynecological malignancies. 
 
Material and Methods: RA plans were generated using double 
arc for a cohort of ten patients using 6 and 10 MV FFFB. Plans 
were generated to deliver a dose of 50.4 Gy in 28 fractions 
for Planning target volume (PTV) and ALARA were used as an 
objective for Organs at risk (OARs). Plans were analysed for 
PTV Coverage, conformity Index (CI), homogeneity index (HI), 
dose to OAR’s, integral dose to normal tissue (NTID) and total 
no. of monitor units (MUs).  
 
Results: The volume of PTV receiving prescription dose were 
95.03+ 0.09% and 95.09+ 0.10%, HI were 1.062+ 0.008 and 
1.066+ 0.008,CI were 1.007+ 0.016 and 1.012+ 0.013, mean 
NTID were 272.2+ 37.1 and 261.1+ 33.2 (liter-Gy), MUs 
number were 629.6+ 31 and 647.2+ 44 for FFFB using 6 and 10 
MV respectively. There were no statistically significant 
(p>0.05) difference found in mean doses to bladder, rectum, 
bowel and both femoral heads for FFFB using 6 and 10 MV 
respectively. There were significant ( p <0.05) difference 
found in HI, MU number and NTID for FFFB using 6 and 10 MV 
respectively.  
 
Conclusion: FFFB of 6MV was found superior in comparison to 
10MV for RA planning in case of gynecological malignancies. 
It offers better HI, CI, less number of MUs (2.8%) and delivers 
more NTID (4.3%) for similar target coverage and OAR’s 
sparing. 
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Purpose or Objective: The purpose of this study is to 
investigate the treatment plan dosimetry and delivery 
efficiency between the single-arc and double-arc techniques 
using stereotactic body radiotherapy with flattening filter 
free beams for early-stage lung cancer. 
 
Material and Methods: Nineteen patients were included in 
this investigation, and each patient was arranged single-
partial-arc (SA) and double-partial-arc (DA) techniques using 
the Eclipse 10.0 treatment planning system. The prescription 
dose was 48Gy/4 fractions and the photon beam energy was 6 
MV flattening filter-free (FFF) beams from Truebeam linear 
accelerator. The treatment plans were appraised by 
Radiation Therapy Oncology Group (RTOG-0915) criteria for 
planning target volume (PTV) coverage and organs at risk 
(OAR) sparing. All plans were normalized to 100% of 
prescribed dose at least covering 95% of the PTV. Treatment 
efficiency was evaluated via monitor units (MUs) and 
treatment times were compared. 
 
Results: The PTV volumes range from 20.46 to 88.37 cm3. 
Compared to the SA and DA plans, there was no significant 
difference in PTV coverage, except the maximum dose in the 
PTV. The maximum dose of SA technique was slightly higher 
than that of DA technique. The mean PTV conformity index 
(CI) for SA and DA was 1.06±0.05 and 1.01±0.03 respectively. 
